focus -WSS

focus

author：explore 2025-09-06 03:55:11 - browse：66

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： House transparency, PBM reform bill gains bipartisan support

WSS

The explosion of genetic testing requires a new approach

UnitedHealth’s board chair also owns a personal investment firm

House transparency, PBM reform bill gains bipartisan support

2023 STAT Wunderkinds: get to know the winners

Advances in CAR

Illumina names Agilent executive as new CEO

focus

focus

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

CEOs share strategies for surviving biotech slump

How one medical school became remarkably diverse

Studies point to risks of excluding people with obesity from drug trials

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How to fix cancer clinical trials' diversity problem

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Amazon on where the company's health care bets are headed next

Malaria cases in Florida and Texas: Here’s what you need to know

Pharmacists can make shortage drugs, but at what cost?

focus

Listen: Biogen's potential pivot, & Illumina's next chapter

FDA gives detailed accounting of AI

STAT Summit: Michael J. Fox on progress in Parkinson's research

STAT Summit: GSK CEO on pharma giant's new direction

Illumina names Agilent executive as new CEO

First Opinion Podcast: Long Covid needs a new approach

knowledge

entertainment

hotspot

hotspot